Hematopoietic stem cell transplantation
E Hatzimichael, M Tuthill - Stem cells and cloning: advances and …, 2010 - Taylor & Francis
More than 25,000 hematopoietic stem cell transplantations (HSCTs) are performed each
year for the treatment of lymphoma, leukemia, immune-deficiency illnesses, congenital …
year for the treatment of lymphoma, leukemia, immune-deficiency illnesses, congenital …
Advances in umbilical cord blood cell therapy: the present and the future
S Berglund, I Magalhaes, A Gaballa… - Expert Opinion on …, 2017 - Taylor & Francis
Introduction: Umbilical cord blood (UCB), previously seen as medical waste, is increasingly
recognized as a valuable source of cells for therapeutic use. The best-known application is …
recognized as a valuable source of cells for therapeutic use. The best-known application is …
Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome
CA Lindemans, R Chiesa, PJ Amrolia… - Blood, The Journal …, 2014 - ashpublications.org
In vivo T-cell depletion might contribute to the delayed immune reconstitution observed after
unrelated umbilical cord blood transplantation (UCBT). We studied the impact of early, late …
unrelated umbilical cord blood transplantation (UCBT). We studied the impact of early, late …
[HTML][HTML] Optimal stem cell source for allogeneic stem cell transplantation for hematological malignancies
DKL Cheuk - World journal of transplantation, 2013 - ncbi.nlm.nih.gov
Hematopoietic stem cell transplant (HSCT) is a standard treatment for many hematological
malignancies. Three different sources of stem cells, namely bone marrow (BM), peripheral …
malignancies. Three different sources of stem cells, namely bone marrow (BM), peripheral …
Umbilical cord blood stem cells: what to expect
XY Zhong, B Zhang, R Asadollahi… - Annals of the New …, 2010 - Wiley Online Library
Umbilical cord blood (UCB) is a valuable alternative source of hematopoietic stem cells
(HSCs). It has unique advantages of easy procurement, absence of risk to donors, low risk of …
(HSCs). It has unique advantages of easy procurement, absence of risk to donors, low risk of …
Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo
SM McGoldrick, ME Bleakley… - Blood, The Journal …, 2013 - ashpublications.org
A disadvantage of umbilical cord blood transplantation (UCBT) is the delay in immune
reconstitution, placing patients at increased risk for infections after transplant …
reconstitution, placing patients at increased risk for infections after transplant …
Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency
M Rizzi, C Neumann, AK Fielding, R Marks… - Journal of allergy and …, 2011 - jacionline.org
* These authors contributed equally to this work. SBEAH was supported by the Dutch Top
Institute Pharma T1-214. Disclosure of potential conflict of interest: SBEA Hoeks has …
Institute Pharma T1-214. Disclosure of potential conflict of interest: SBEA Hoeks has …
Risk factors for acute kidney injury in pediatric patients after hematopoietic stem cell transplantation: A systematic review and meta-analysis
B Huang, J Shan, L Yi, Y Xin, Z Zhong, H Xu - Pediatric Nephrology, 2024 - Springer
Background Risk factors for acute kidney injury (AKI) in pediatric patients after hematopoietic
stem cell transplantation (HSCT) remain controversial. Objectives This study aimed to …
stem cell transplantation (HSCT) remain controversial. Objectives This study aimed to …
[HTML][HTML] A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in acute leukemia patients
H Zhang, J Chen, W Que - Biology of Blood and Marrow Transplantation, 2012 - Elsevier
Umbilical cord blood has emerged as an alternative stem cell source to bone marrow or
peripheral blood stem cells. Umbilical cord blood transplantation (UCBT) is also potentially …
peripheral blood stem cells. Umbilical cord blood transplantation (UCBT) is also potentially …
Critical role for programmed death 1 signaling and protein kinase B in augmented regulatory T-cell induction in cord blood
S de Roock, SBEA Hoeks, L Meurs, A Steur… - Journal of allergy and …, 2011 - jacionline.org
LETTERS TO THE EDITOR 1369 difference (Fig 1, A). Induced CB FOXP3 1 T cells (sorted
as CD4 1 CD25 1 CD127low cells) were able to suppress dose dependently the …
as CD4 1 CD25 1 CD127low cells) were able to suppress dose dependently the …